This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction:Impact of race on outcomes in the treatment of intracranial aneurysm (IA) remains unclear. Data from 9 centers in the United States, Europe, and Asia for IA patients who undertook endovascular treatment (EVT) or microsurgical treatment (MST) between January 2016 and December 2020 were included for analysis.
IntroductionInfectious Intracranial Aneurysms (IIAs), commonly referred to as mycotic aneurysms, are a common sequela of infective endocarditis (IE). The median (minimum‐maximum) number of days between securing aneurysms to valvular surgery was 18 (10‐29). Only 2/41 (4.9%) IIAs were detected following valvular surgery.
IntroductionInfectious intracranial aneurysms (IIAs), commonly referred to as mycotic aneurysms, are a common sequela of infective endocarditis (IE). Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The morbidity rate is known to be about 80% in ruptured IIAs.
Background:While predictors of seizure in aneurysmal subarachnoid hemorrhage (aSAH) patients have been explored, predictors for seizure in patients with angiogram-negative non-perimesencephalic SAH (an-NPSAH) are less understood. Neither intracerebral hemorrhage nor aneurysm securement modality was associated with seizure.
Background:Cerebral vasospasm is a well-known complication after aneurysmal subarachnoid hemorrhage (aSAH) and occurs more commonly in younger patients. Stroke, Volume 55, Issue Suppl_1 , Page AWP139-AWP139, February 1, 2024. Vasospasm was defined based on transcranial Doppler (TCD) criteria.
Background:Cisternal score (CISCO), which is calculated based on quantification of blood clot in basal cisterns, has been shown to have good accuracy in predicting ventriculoperitoneal shunt requirement in patients with aneurysmal subarachnoid hemorrhage (aSAH). Data was collected prospectively as part of a quality improvement project.
We sought to identify predictors of discharge from extended care facilities to home in aSAH patients.Methods:We conducted a retrospective review of a prospectively maintained database of aSAH patients treated at a single center from June 2016 to March 2024. Included patients were discharged from the hospital to an extended care facility.
Our study aims to describe the trends and outcomes of patients with Subarachnoid Hemorrhage (SAH) using a Nationwide Inpatient Sample (NIS) database.Methods:We examined the 2016-2020 NIS database, focusing on patients aged 18 years and older with a primary SAH discharge diagnosis. years with 72,650 (61.0%) being female.
BackgroundPatent foramen ovale (PFO) is causally associated with stroke in some patients younger than 60 years, especially when it is large or associated with an atrial septal aneurysm (ASA). After 60 years of age, this association is less well understood.
This study aims to describe outcomes and determinants of outcomes in pediatric patients with SAH.Methods:We reviewed all pediatric admissions with the primary diagnosis of SAH from the 2016-2020 National Inpatient Sample using International Classification of Disease Codes. Median length of hospitalization was 9.7 days (95% CI, 8.2-11.2.
In this study, we aim to study trends in EC-IC bypass throughout the years.Methods:Using the National Inpatient Sample 2016-2019, hospital admissions with carotid occlusive disease (COD), moyamoya, subarachnoid hemorrhage (SAH), unruptured intracranial aneurysm (UIA) were identified using ICD-10 diagnosis codes.
IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures.
A cerebral aneurysm (CA) is an abnormal artery deformation in the brain that may lead to hemorrhagic stroke, brain damage, coma, and even death when a CA ruptures. We revisited unruptured CA transcriptomes, pooling 3 datasets from 6 manuscripts published between 2016 and 2021 for a total of 100 samples (38 normal and 62 unruptured CA).
Background:According to the 2023 guidelines for the management of patients with aneurysmal subarachnoid hemorrhages (SAH), early treatment of ruptured aneurysms reduces the risk of repeated bleeds and facilitates treatment of delayed cerebral ischemia. No differences were noted in the size or location of aneurysm.
IntroductionInfectious intracranial aneurysms (IIAs), commonly referred to as mycotic aneurysms, are a common sequela of infective endocarditis (IE). Mortality rates have been reported up to 30% for unruptured and 80% for ruptured mycotic aneurysms. The average (minimum‐maximum; mm) size of ruptured IIAs was 3.3 (0.2‐11)
There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. We aimed to investigate the impact of COVID‐19 on the overall complications, including ischemic stroke and subarachnoid hemorrhage (SAH) rates in patients treated for intracranial aneurysms (IAs).MethodsThis
BackgroundDelayed cerebral ischemia represents a significant contributor to death and disability following aneurysmal subarachnoid hemorrhage. Journal of the American Heart Association, Ahead of Print. Our analysis included 102 eligible studies.
Methods:We studied a population-level cohort of all patients diagnosed with IS/TIA in an entire Canadian province (Alberta) from April 1, 2016, to March 31, 2017, followed for at least 5 years until March 31,2022 for recurrent IS/TIA using administrative health data. Concomitant intracranial or extracranial aneurysms were detected in 9.1%(Table
Cerebral aneurysms (CA) arise from the sites of weakened artery walls in the brain, and they may cause hemorrhagic stroke, coma, and death when they rupture. Stroke, Volume 56, Issue Suppl_1 , Page ATMP3-ATMP3, February 1, 2025. Studies have revealed sex differences in ~1.5 times higher prevalence of CA and ~1.5
Look for Vascular Etiology -- think of these while doing H and P: --Bleeding: ruptured AAA, GI bleed, ruptured ectopic pregnancy, other spontaneous bleed such as mesenteric aneurysms. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
40 
Let's personalize your content